Adar1 Capital Management, LLC Alkermes Plc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 74,431 shares of ALKS stock, worth $2.35 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
74,431
Previous 196,577
62.14%
Holding current value
$2.35 Million
Previous $4.74 Billion
56.02%
% of portfolio
0.34%
Previous 0.89%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
359Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$918 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$598 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$410 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$399 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$290 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.18B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...